Literature DB >> 26541482

The central role of hypothalamic inflammation in the acute illness response and cachexia.

Kevin G Burfeind1,2, Katherine A Michaelis1,2, Daniel L Marks1.   

Abstract

When challenged with a variety of inflammatory threats, multiple systems across the body undergo physiological responses to promote defense and survival. The constellation of fever, anorexia, and fatigue is known as the acute illness response, and represents an adaptive behavioral and physiological reaction to stimuli such as infection. On the other end of the spectrum, cachexia is a deadly and clinically challenging syndrome involving anorexia, fatigue, and muscle wasting. Both of these processes are governed by inflammatory mediators including cytokines, chemokines, and immune cells. Though the effects of cachexia can be partially explained by direct effects of disease processes on wasting tissues, a growing body of evidence shows the central nervous system (CNS) also plays an essential mechanistic role in cachexia. In the context of inflammatory stress, the hypothalamus integrates signals from peripheral systems, which it translates into neuroendocrine perturbations, altered neuronal signaling, and global metabolic derangements. Therefore, we will discuss how hypothalamic inflammation is an essential driver of both the acute illness response and cachexia, and why this organ is uniquely equipped to generate and maintain chronic inflammation. First, we will focus on the role of the hypothalamus in acute responses to dietary and infectious stimuli. Next, we will discuss the role of cytokines in driving homeostatic disequilibrium, resulting in muscle wasting, anorexia, and weight loss. Finally, we will address mechanisms and mediators of chronic hypothalamic inflammation, including endothelial cells, chemokines, and peripheral leukocytes.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute illness response; Cachexia; Hypothalamus; Neuroinflammation

Mesh:

Year:  2015        PMID: 26541482      PMCID: PMC4872506          DOI: 10.1016/j.semcdb.2015.10.038

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  160 in total

Review 1.  The design of barriers in the hypothalamus allows the median eminence and the arcuate nucleus to enjoy private milieus: the former opens to the portal blood and the latter to the cerebrospinal fluid.

Authors:  Esteban M Rodríguez; Juan L Blázquez; Montserrat Guerra
Journal:  Peptides       Date:  2010-01-20       Impact factor: 3.750

2.  Distribution of Fos-like immunoreactivity in the rat brain following intravenous lipopolysaccharide administration.

Authors:  J K Elmquist; T E Scammell; C D Jacobson; C B Saper
Journal:  J Comp Neurol       Date:  1996-07-15       Impact factor: 3.215

Review 3.  Leukemia inhibitory factor (LIF).

Authors:  Nicos A Nicola; Jeffrey J Babon
Journal:  Cytokine Growth Factor Rev       Date:  2015-07-04       Impact factor: 7.638

4.  Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide.

Authors:  K Tatemoto; M Carlquist; V Mutt
Journal:  Nature       Date:  1982-04-15       Impact factor: 49.962

5.  TNF-α transiently induces endoplasmic reticulum stress and an incomplete unfolded protein response in the hypothalamus.

Authors:  R G Denis; A P Arruda; T Romanatto; M Milanski; A Coope; C Solon; D S Razolli; L A Velloso
Journal:  Neuroscience       Date:  2010-08-13       Impact factor: 3.590

6.  Chronic central nervous system exposure to interleukin-1 beta causes catabolism in the rat.

Authors:  A G Hill; L Jacobson; J Gonzalez; J Rounds; J A Majzoub; D W Wilmore
Journal:  Am J Physiol       Date:  1996-11

7.  Lipopolysaccharide (LPS)- and muramyl dipeptide (MDP)-induced anorexia during refeeding following acute fasting: characterization of brain cytokine and neuropeptide systems mRNAs.

Authors:  D Gayle; S E Ilyin; M C Flynn; C R Plata-Salamán
Journal:  Brain Res       Date:  1998-06-08       Impact factor: 3.252

8.  Type 1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation.

Authors:  A Ericsson; C Liu; R P Hart; P E Sawchenko
Journal:  J Comp Neurol       Date:  1995-10-30       Impact factor: 3.215

9.  Protein kinase C-α signals P115RhoGEF phosphorylation and RhoA activation in TNF-α-induced mouse brain microvascular endothelial cell barrier dysfunction.

Authors:  Jing Peng; Fang He; Ciliu Zhang; Xiaolu Deng; Fei Yin
Journal:  J Neuroinflammation       Date:  2011-04-08       Impact factor: 8.322

10.  Interleukin-1beta induced vascular permeability is dependent on induction of endothelial tissue factor (TF) activity.

Authors:  Markus Puhlmann; David M Weinreich; Jeffrey M Farma; Nancy M Carroll; Ewa M Turner; H Richard Alexander
Journal:  J Transl Med       Date:  2005-09-30       Impact factor: 5.531

View more
  36 in total

1.  TRIF is a key inflammatory mediator of acute sickness behavior and cancer cachexia.

Authors:  Kevin G Burfeind; Xinxia Zhu; Peter R Levasseur; Katherine A Michaelis; Mason A Norgard; Daniel L Marks
Journal:  Brain Behav Immun       Date:  2018-05-28       Impact factor: 7.217

2.  Gut Hormone GIP Induces Inflammation and Insulin Resistance in the Hypothalamus.

Authors:  Yukiko Fu; Kentaro Kaneko; Hsiao-Yun Lin; Qianxing Mo; Yong Xu; Takayoshi Suganami; Peter Ravn; Makoto Fukuda
Journal:  Endocrinology       Date:  2020-09-01       Impact factor: 4.736

3.  Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome.

Authors:  Matthew C Morris; Katherine E Cooney; Hooman Sedghamiz; Maria Abreu; Fanny Collado; Elizabeth G Balbin; Travis J A Craddock; Nancy G Klimas; Gordon Broderick; Mary Ann Fletcher
Journal:  Clin Ther       Date:  2019-03-28       Impact factor: 3.393

Review 4.  STAT3 in the systemic inflammation of cancer cachexia.

Authors:  Teresa A Zimmers; Melissa L Fishel; Andrea Bonetto
Journal:  Semin Cell Dev Biol       Date:  2016-02-06       Impact factor: 7.727

5.  Respiratory Syncytial Virus (RSV) Pulmonary Infection in Humanized Mice Induces Human Anti-RSV Immune Responses and Pathology.

Authors:  Anurag Sharma; Wenzhu Wu; Biin Sung; Jing Huang; Tiffany Tsao; Xiangming Li; Rika Gomi; Moriya Tsuji; Stefan Worgall
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

Review 6.  Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation.

Authors:  Kevin G Burfeind; Vijayshree Yadav; Daniel L Marks
Journal:  Curr Neurol Neurosci Rep       Date:  2016-11       Impact factor: 5.081

7.  Persistent Toll-like receptor 7 stimulation induces behavioral and molecular innate immune tolerance.

Authors:  Katherine A Michaelis; Mason A Norgard; Peter R Levasseur; Brennan Olson; Kevin G Burfeind; Abigail C Buenafe; Xinxia Zhu; Sophia Jeng; Shannon K McWeeney; Daniel L Marks
Journal:  Brain Behav Immun       Date:  2019-09-06       Impact factor: 7.217

8.  Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer.

Authors:  Kevin G Burfeind; Xinxia Zhu; Mason A Norgard; Peter R Levasseur; Christian Huisman; Abigail C Buenafe; Brennan Olson; Katherine A Michaelis; Eileen Rs Torres; Sophia Jeng; Shannon McWeeney; Jacob Raber; Daniel L Marks
Journal:  Elife       Date:  2020-05-11       Impact factor: 8.140

9.  Melanocortin-4 receptor antagonist TCMCB07 ameliorates cancer- and chronic kidney disease-associated cachexia.

Authors:  Xinxia Zhu; Michael F Callahan; Kenneth A Gruber; Marek Szumowski; Daniel L Marks
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

Review 10.  Understanding cachexia in the context of metastatic progression.

Authors:  Anup K Biswas; Swarnali Acharyya
Journal:  Nat Rev Cancer       Date:  2020-03-31       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.